Skip to main content
OSCOTECInc. logo

OSCOTECInc. — Investor Relations & Filings

Ticker · 039200 ISIN · KR7039200001 KO Manufacturing
Filings indexed 277 across all filing types
Latest filing 2020-02-17 Proxy Solicitation & In…
Country KR South Korea
Listing KO 039200

About OSCOTECInc.

https://oscotec.com/

Oscotec Inc. is a clinical-stage drug discovery and development company focused on translating scientific research into innovative medicines for clinically unmet needs. The company's development pipeline targets various diseases, with a primary focus on immunology, oncology, and neurodegenerative disorders. Key therapeutic areas include rheumatoid arthritis, immune thrombocytopenia, non-small cell lung cancer, acute myeloid leukemia, and Alzheimer's disease. Oscotec specializes in developing novel kinase inhibitors, such as Spleen Tyrosine Kinase (SYK) inhibitors, to address these conditions.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company Oscotec. It outlines the date, location, and agenda items (such as financial statement approval, director/auditor appointments, and remuneration limits). This document is a standard proxy solicitation material sent to shareholders to inform them of the upcoming meeting and the items to be voted upon, which fits the definition of a Proxy Solicitation & Information Statement (PSI).
2020-02-17 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 95% confidence The document is a regulatory filing from a Korean company (Oscotec) announcing a significant change (over 30%) in revenue or profit structure. This is a standard regulatory disclosure requirement in the Korean market (DART system) for material financial changes. It provides specific financial data (revenue, operating profit, net income) and the reasons for the change, but it is not a full annual report or an earnings release presentation. It fits the 'Regulatory Filings' category as it is a mandatory disclosure of material information.
2020-01-29 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and the Korea Exchange. This type of filing is used to report changes in significant share ownership (crossing thresholds or changes in major holdings) by major shareholders and their special related parties. In the provided classification schema, this corresponds to a 'Major Shareholding Notification'.
2019-12-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the personal share transactions (disposals) of an executive (Kim Jung-Ho) of the company Oscotec. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports insider trading activities by company management.
2019-12-30 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a third-party paid-in capital increase). It details the type of security (convertible preferred shares), the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2019-12-26 Korean
증권발행결과(자율공시)(제12회차 CB)
Capital/Financing Update Classification · 100% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement from OscoTec, detailing the issuance of convertible bonds (CB). This falls under the category of capital and financing updates, specifically regarding the completion of a financing activity.
2019-12-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.